Roy Kishony
קישוני, רועי
Kishony, Roy
VIAF ID: 51156130870758310350 (Personal)
Permalink: http://viaf.org/viaf/51156130870758310350
Preferred Forms
-
- 100 0 _ ‡a Roy Kishony
-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Accelerated evolution of resistance in multidrug environments | |
Additivity of inhibitory effects in multidrug combinations | |
Analysis of genetic systems using experimental evolution and whole-genome sequencing | |
Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis | |
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities | |
Bacterial persistence: a model of survival in changing environments | |
Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. | |
A competitive trade-off limits the selective advantage of increased antibiotic production | |
Compounds that select against the tetracycline-resistance efflux pump | |
Concordance between epidemiological evaluation of probability of transmission and whole genome sequence relatedness among hospitalized patients acquiring KPC-producing Klebsiella pneumoniae | |
Counteraction of antibiotic production and degradation stabilizes microbial communities | |
Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus | |
Distinct growth strategies of soil bacteria as revealed by large-scale colony tracking | |
Distinct single-cell morphological dynamics under beta-lactam antibiotics | |
Drug interactions modulate the potential for evolution of resistance | |
Dynamic phenotypic clustering in noisy ecosystems | |
Editorial overview: Antimicrobials: grappling with the complexities of antibiotics and resistance | |
Environmental stresses can alleviate the average deleterious effect of mutations | |
An equivalence principle for the incorporation of favorable mutations in asexual populations. | |
Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor | |
Evaluation of COVID-19 RT-qPCR test in multi-sample pools | |
Evolthon: A community endeavor to evolve lab evolution | |
Evolution and multilevel optimization of the genetic code | |
Evolution exacerbates the paradox of the plankton | |
The evolutionary dynamics of the Saccharomyces cerevisiae protein interaction network after duplication | |
Exposing the fitness contribution of duplicated genes | |
Functional classification of drugs by properties of their pairwise interactions. | |
Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. | |
Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients | |
Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis. | |
Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung. | |
High-order species interactions shape ecosystem diversity | |
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway | |
Hydroxyurea triggers cellular responses that actively cause bacterial cell death | |
Inexpensive multiplexed library preparation for megabase-sized genomes | |
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | |
Modular epistasis in yeast metabolism. | |
Multidrug evolutionary strategies to reverse antibiotic resistance | |
Need-based up-regulation of protein levels in response to deletion of their duplicate genes | |
Networks from drug-drug surfaces | |
Nongenetic individuality in the host-phage interaction | |
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions | |
Opposing effects of target overexpression reveal drug mechanisms | |
Optimal drug synergy in antimicrobial treatments | |
Optimization and control in bacterial lag phase | |
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. | |
Personal clinical history predicts antibiotic resistance of urinary tract infections | |
Polyploidy can drive rapid adaptation in yeast | |
Quiet Gene Circuit More Fragile Than Its Noisy Peer | |
Rapid beta-lactam-induced lysis requires successful assembly of the cell division machinery | |
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections | |
Regulation of cell size in response to nutrient availability by fatty acid biosynthesis in Escherichia coli | |
Regulatory Dynamics Determine Cell Fate following Abrupt Antibiotic Exposure. | |
Resolution of gene regulatory conflicts caused by combinations of antibiotics | |
RNA Structural Determinants of Optimal Codons Revealed by MAGE-Seq. | |
SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates | |
A simple direct RT-LAMP SARS-CoV-2 saliva diagnostic | |
Size Laws and Division Ring Dynamics in Filamentous Escherichia coli cells. | |
Spatiotemporal microbial evolution on antibiotic landscapes | |
A spotlight on bacterial mutations for 75 years | |
Structure and evolution of Streptomyces interaction networks in soil and in silico | |
Systems biology | |
Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection | |
Transient antibiotic resistance calls for attention | |
Ubiquitous selection for mecA in community-associated MRSA across diverse chemical environments | |
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. | |
What counters antibiotic resistance in nature? |